Overview

• US healthcare data platform's Q1 revenue rose 5.8%, beating analyst expectations

• Q1 adjusted EBITDA increased 3.4% and slightly beat analyst expectations

• Company raised 2026 revenue guidance, kept other outlook metrics unchanged

Outlook

• Claritev raises 2026 revenue guidance to $985 mln-$1 bln from $980 mln-$1 bln

• Company maintains 2026 Adjusted EBITDA guidance at $605 mln-$615 mln

• Claritev expects continued growth from expansion into provider and government verticals

Result Drivers

• CORE BUSINESS CONSISTENCY - Co said consistent performance in its core business drove Q1 revenue and adjusted EBITDA growth

• EXPANSION INTO NEW VERTICALS - Co cited growth from expansion into provider and government verticals, leading to more diversified revenue streams

• AI APPLICATIONS - Co said differentiated application of AI is helping accelerate progress and support growth

Company press release: ID:nBw6JTc60a

Key Details

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.